U.K. MIDWEEKS: A VOTE FOR KENNEDY

Dermot Kennedy is set to claim his second U.K. Official Albums #1, with Sonder (Island). On singles, Taylor Swift's “Anti-Hero” (EMI) remains on top.

At the week's halfway point, Sonder has a lead of 12k in sales over its closest competition—Swift’s Midnights, at #2.

Queen is also new, at #3 today with an eight-disc reissue of ’89 album The Miracle (EMI). The set joins a number of re-releases in the midweek Top 40, among them Michael Jackson’s 40th anniversary version of Thriller (MJJ), at #11.

Andre Rieu and his Johann Strauss Orchestra are pacing for a #4 debut, with Silver Bells (Decca) at #4, while Nickelback’s Get Rollin’ (BMG) is new at #5.

David Bowie could secure another posthumous Top 10 collection with the original soundtrack to Brett Morgen's documentary Moonage Daydream (Parlophone), at #7. Disturbed’s Divisive (Reprise) is also heading for a Top 10 debut, at #8.

On the U.K.’s Official Singles Chart, Swift’s “Anti-Hero” looks set to claim a fifth week at #1 on Friday.

Meghan Trainor’s “Made You Look” (RCA) is up one to #3 as “Psycho” (Atlantic) by Anne-Marie and Aitch also jumps one, to #6. This week’s highest new entry is from London rapper Clavish, who joins forces with D-Block Europe for “Rocket Science” (Polydor), at #9.

Following the arrival of Sonder, Kennedy’s “Kiss Me” is up to #12 from #21. Stormzy’s “Firebabe” (Def Jam 0207) is also set to rise, up nine places to #17 midweek.

HITS LIST GETS LIT UP
Whoa, this year's going too fast. (11/16a)
NEAR TRUTHS: THE ELEPHANT IN THE ROOM
Nervous time in the music biz and beyond. (11/16a)
GRAMMY CHEW: RUMINATING ON THE BIG 4 NOMS
80% is a lot better than usual. (11/15a)
LINKIN PARK CHATS NEW LP WITH AMAZON MUSIC
Alexa's ready to rock. (11/15a)
AND THE 2025 GRAMMY NOMINEES ARE...
And away we go. (11/8a)
NOW WHAT?
We have no fucking idea.
COUNTRY'S NEWEST DISRUPTOR
Three chords and some truth you may not be ready for.
AI IS ALREADY EATING YOUR LUNCH
The kids can tell the difference... for now.
WHO'S BUYING THE DRINKS?
That's what we'd like to know.
 Email

 First Name

 Last Name

 Company

 Country